Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert P Finger

Showing results (101-110 of 296) with videos related to

Pageof 30
Sort By:
Ophthalmic Epidemiology|March 14, 2017
Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of SmokingMyra B McGuinness, Amalia Karahalios, Jessica Kasza, et al.
Die Ophthalmologie|June 13, 2025
[Risk factors for age-related macular degeneration : Lessons learned from current data]Caroline Brandl, Iris M Heid, H Helbig, et al.
The British Journal of Ophthalmology|November 13, 2019
Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysisJeany Q Li, Thomas Welchowski, Matthias Schmid, et al.
Advances in Therapy|June 9, 2022
Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-AnalysisRobert P Finger, Natalie Dennis, Rita Freitas, et al.
Investigative Ophthalmology & Visual Science|January 24, 2013
Evaluation of a vision-related utility instrument: the German vision and quality of life indexRobert P Finger, Karsten Kortuem, Eva Fenwick, et al.
Investigative Ophthalmology & Visual Science|September 6, 2014
Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocolRobert P Finger, Betty Tellis, Julie Crewe, et al.
Die Ophthalmologie|April 14, 2026
Risk factors for age-related macular degenerationCaroline Brandl, Iris M Heid, H Helbig, et al.
Ophthalmology and Therapy|June 1, 2024
Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative ReviewIan M Leitch, Michael Gerometta, David Eichenbaum, et al.
Investigative Ophthalmology & Visual Science|October 30, 2018
Retest Reliability of Mesopic and Dark-Adapted Microperimetry in Patients With Intermediate Age-Related Macular Degeneration and Age-Matched ControlsSusanne G Welker, Maximilian Pfau, Manuel Heinemann, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 3, 2021
[The Treatment Exit Options for Uveitis (TOFU) Registry: Involving Patients in the Generation of Evidence]Jeany Q Li, Jennifer Dell, Tobias Höller, et al.
Pageof 30

Showing results (101-110 of 296) with videos related to

Sort By:
Pageof 30
Ophthalmic Epidemiology|March 14, 2017
Survival Bias When Assessing Risk Factors for Age-Related Macular Degeneration: A Tutorial with Application to the Exposure of SmokingMyra B McGuinness, Amalia Karahalios, Jessica Kasza, et al.
Die Ophthalmologie|June 13, 2025
[Risk factors for age-related macular degeneration : Lessons learned from current data]Caroline Brandl, Iris M Heid, H Helbig, et al.
The British Journal of Ophthalmology|November 13, 2019
Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysisJeany Q Li, Thomas Welchowski, Matthias Schmid, et al.
Advances in Therapy|June 9, 2022
Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-AnalysisRobert P Finger, Natalie Dennis, Rita Freitas, et al.
Investigative Ophthalmology & Visual Science|January 24, 2013
Evaluation of a vision-related utility instrument: the German vision and quality of life indexRobert P Finger, Karsten Kortuem, Eva Fenwick, et al.
Investigative Ophthalmology & Visual Science|September 6, 2014
Developing the impact of Vision Impairment-Very Low Vision (IVI-VLV) questionnaire as part of the LoVADA protocolRobert P Finger, Betty Tellis, Julie Crewe, et al.
Die Ophthalmologie|April 14, 2026
Risk factors for age-related macular degenerationCaroline Brandl, Iris M Heid, H Helbig, et al.
Ophthalmology and Therapy|June 1, 2024
Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative ReviewIan M Leitch, Michael Gerometta, David Eichenbaum, et al.
Investigative Ophthalmology & Visual Science|October 30, 2018
Retest Reliability of Mesopic and Dark-Adapted Microperimetry in Patients With Intermediate Age-Related Macular Degeneration and Age-Matched ControlsSusanne G Welker, Maximilian Pfau, Manuel Heinemann, et al.
Gesundheitswesen (Bundesverband Der Arzte Des Offentlichen Gesundheitsdienstes (Germany))|November 3, 2021
[The Treatment Exit Options for Uveitis (TOFU) Registry: Involving Patients in the Generation of Evidence]Jeany Q Li, Jennifer Dell, Tobias Höller, et al.
Pageof 30